Use access key #2 to skip to page content.
$5.71 -0.34 (-5.62%)
8/21/2008 4:00 PM

Exelixis, Inc. (EXEL)

CAPS Rating:
****

A development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases.

View All Commentary (EXEL)

Recs

4

Avatar Gatsby01 (30.43) Submitted: 3/02/08 10:05 PM : Outperform Start Price: $6.62 EXEL Score: -9.74

This pick is definitely outside my comfort zone. I feel like I am betting on my golf game ( which is not that good) but I have bought a few mulligans to improve the odds. Thanks to the Fool for bringing it to my attention and explaiing the rationale for this potential racehorse.

I am on my way to the range to practice.

Report this Post Replies: 0 | Reply

Featured Broker Partners